Search This Blog

Wednesday, July 29, 2020

Taro Pharmaceutical EPS of -$11.37

Taro Pharmaceutical (NYSE:TARO): Q1 EPS of -$11.37 may not be comparable to consensus of $1.16.
Revenue of $117.63M (-27.1% Y/Y) misses by $40.72M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)